Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

WEI Long-jing. Studies on compliance in the treatment of depression[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 415-417,474. doi: 10.3969/j.issn.1006-0111.2012.06.005
Citation: WEI Long-jing. Studies on compliance in the treatment of depression[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 415-417,474. doi: 10.3969/j.issn.1006-0111.2012.06.005

Studies on compliance in the treatment of depression

doi: 10.3969/j.issn.1006-0111.2012.06.005
  • Received Date: 2012-02-02
  • Rev Recd Date: 2012-04-25
  • The definition, evaluation methods, grade classification, research status, influence factors and intervention measures of the compliance in the treatment of depression were reviewed in this paper based on the literatures home and aboard. It was clarified that the compliance in the treatment of depression was effected jointly by several factors. Making intervention plan for patients individually could improve the anti-depressant adherence and had a greater decrease in depressive symptoms. The review was to attract more attention to the study on compliance in the treatment of depression and offer some references to the related research.
  • [1] NIMH/NIH Consensus Development Panel.Mood disorders:pharmacological prevention of recurrences[J].Am J Psychiatry,1985,142:469.
    [2] Frank E,Kupfer DJ,Perel JM,et al.Three-year outcomes for maintenance therapies in recurrent depression[J].Arch Gen Psychiatry,1990,47(12):1093.
    [3] Kupfer DJ,Frank E,Perel JM,et al.Five-year outcome for maintenance therapies in recurrent depression[J].Arch Gen Psychiatry,1992,49(10):769.
    [4] Greden JF.Antidepressant maintenance medications:when to discontinue and how to stop[J].J Clin Psychiatry,1993,54(Suppl 8):39.
    [5] Haynes RB,Taylor DW,Sackett DL. Compliance in Health Care[M].Baltimore:The Johns Hopkins University Press,1979:1
    [6] Frank E,Perel JM,Mallinger AG,et al.Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression[J].Psychopharmacol Bulletin,1992,28(3):231.
    [7] Demyttenaere K.Compliance during treatment with antidepressants[J].J Affect Disorders,1997,43(1):27.
    [8] Tollefson GD. Adverse drug reactions/interactions in maintenance therapy[J]. J Clin Psychiatry,1993,54(Suppl 8):48.
    [9] Altamura AC,Mauri M.Plasma concentrations,information and therapy adherence during long-term treat-ment with antidepressants[J].Br J Clin Pharmacol,1985,20(6):714.
    [10] Kruse W,Weber E.Dynamics of drug regimen compliance-its assessment by microprocessor-based monitoring[J].Eur J Pharmacol,1990,38(6):561.
    [11] George CF,Peveler RC,Heiliger S,et al.Compliance with tricyclic antidepressants:the value of four different methods of assesment[J].Br J Clin Pharmacol,2000,50(2):166.
    [12] Demyttenaere K,Adelin A,Patrick M,et al.Six-month compliance with antidepressant medication in the treatment of major depressive disorder[J].Int Clin Psychopharmacol,2008,23(1):36.
    [13] Demyttenaere K.Risk factors and predictors of compliance in depression[J]. Eur Neuropsychopharmacol,2003,13 (Suppl 3):S69.
    [14] DiMatteo MR,Lepper HS,CroghanTW.Depression is a risk factor for non-compliance with medical treatment:meta-analysis of the effects of anxiety and depression on patient adherence[J].Arch Intern Med,2000,160(14):2101.
    [15] Sirey JA,Bruce ML,Alexopoulos GS,et al.Stigma as a barrier to recovery:Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence[J].Psychiatric Services,2001,52(12):1615.
    [16] Åkerblad AC,Bengtsson F,Holgersson M,et al.Identification of primary care patients at risk of nonadherence to antidepressant treatment[J].Patient Prefer Adherence,2008,2:379.
    [17] Compton MT,Rudisch BE,Weiss PS,et al.Predictors of psychiatristreported treatment-compliance problems among patients in routine US psychiatric care[J].Psychiatry Res,2005,137(1):29.
    [18] Kamali M,Kelly BD,Clarke M,et al.A prospective evaluation of adherence to medication in first episode schizophrenia[J].Eur Psychiatry,2006,21(1):29.
    [19] Demyttenaere K,Van Ganse E,Gregoire J,et al.Compliance in depressed patients treated with fluoxetine or amitriptyline[J].Int Clin Psychopharmacol,1998,13(1):11.
    [20] DiMatteo MR,Sherbourne CD,Hays RD,et al.Physicians' characteristics influence patients'adherence to medical treatment:results from the medical outcomes study[J].Health Psychol,1993,12(2):93.
    [21] Delgado PL.Approaches to the enhancement of patient adherence to antidepressant medication treatment[J].J Clin Psychiatry,2000,61(suppl 2):6.
    [22] Peveler R,George C,Kinmouth AL,et al. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care:randomized controlled trial[J]. BMJ,1999,319(7210):612.
    [23] Åkerblad AC,Bengtsson F,Ekselius L,et al.Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners[J].Int Clin Psychopharmacol,2003,18(6):347.
    [24] Sirey JA,Bruce ML,Kales HC.Improving Antidepressant Adherence and Depression Outcomes in Primary Care:The Treatment Initiation and Participation (TIP) Program[J].Am J Geriatr Psychiatry,2010,18(6):554.
    [25] 张慧敏,黄贞杰,许晶,等.健康教育干预对综合医院抑郁症治疗依从性的影响[J].临床心理卫生,2007,21(9):630.
    [26] 张慧敏,许晶,李明,等.抑郁症治疗依从性的相关因素分析[J].中国临床康复,2006,10(46):16.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(6260) PDF downloads(1909) Cited by()

Related
Proportional views

Studies on compliance in the treatment of depression

doi: 10.3969/j.issn.1006-0111.2012.06.005

Abstract: The definition, evaluation methods, grade classification, research status, influence factors and intervention measures of the compliance in the treatment of depression were reviewed in this paper based on the literatures home and aboard. It was clarified that the compliance in the treatment of depression was effected jointly by several factors. Making intervention plan for patients individually could improve the anti-depressant adherence and had a greater decrease in depressive symptoms. The review was to attract more attention to the study on compliance in the treatment of depression and offer some references to the related research.

WEI Long-jing. Studies on compliance in the treatment of depression[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 415-417,474. doi: 10.3969/j.issn.1006-0111.2012.06.005
Citation: WEI Long-jing. Studies on compliance in the treatment of depression[J]. Journal of Pharmaceutical Practice and Service, 2012, 30(6): 415-417,474. doi: 10.3969/j.issn.1006-0111.2012.06.005
Reference (26)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return